Eli Lilly's profit rises 6.4% on diabetes drug strength

This post was originally published on this site

Net income rose to $1.41 billion, or $1.55 per share, in the quarter ended June 30, from $1.33 billion, or $1.44 per share, a year earlier.

Lilly said profit was also boosted by its investments in securities, including two U.S.-based companies that had successful initial public offerings in the second quarter of 2020.

Add Comment